[Shock as an adverse reaction to rituximab: Case report].

Rituximab is a plausible alternative first-line treatment of ANCA-associated vasculitis. Adverse effects related to its infusion are common and usually have a benign course. However, there have been reports of refractory cardiogenic shock simulating septic shock.

[Bacteremic colangitis in adults in a general hospital in Chile].

Background: Some aspects of bacteremic cholangitis are unknown in Chile.

Aim: To gather more information on clinical, microbiological aspects as well as risk factors for ICU admission, recurrence and antimicrobial resistance.

Material And Methods: A retrospective research was performed using medical records of adult patients in a general hospital.